ETC
RYTM icon

Exchange Traded Concepts’s Rhythm Pharmaceuticals RYTM Stock Holding History

Exchange Traded Concepts’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$884K Sell
7,966
-497
-6% -$44.9K ﹤0.01% 978
2026
Q1 		$736K Buy
8,463
+2,383
+39% +$232K 0.01% 934
2025
Q4 		$651K Sell
6,080
-306
-5% -$32.5K 0.01% 957
2025
Q3 		$645K Buy
+6,386
New +$593K 0.01% 962
2025
Q2 		– Sell
-11,912
Closed -$631K – 1490
2025
Q1 		$631K Sell
11,912
-463
-4% -$25.7K 0.01% 751
2024
Q4 		$693K Sell
12,375
-2,682
-18% -$148K 0.01% 726
2024
Q3 		$789K Buy
15,057
+3,137
+26% +$150K 0.02% 616
2024
Q2 		$489K Buy
+11,920
New +$476K 0.01% 707

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Exchange Traded Concepts's RYTM Position: Q2 2026 in Review

Exchange Traded Concepts reduced its Rhythm Pharmaceuticals (RYTM) stake by 5.9% in Q2 2026, selling an estimated $44.9K and leaving 7,966 shares worth $884K. The position accounts for ﹤0.01% of the portfolio, ranked #978.

Exchange Traded Concepts first reported a position in RYTM in Q2 2024 and has held it in 8 quarters since. 305 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Exchange Traded Concepts held 7,966 shares of Rhythm Pharmaceuticals worth $884K as of Q2 2026.
  • Exchange Traded Concepts sold 497 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $44.9K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Exchange Traded Concepts's portfolio in Q2 2026, its #978 holding.
  • Exchange Traded Concepts first reported a position in Rhythm Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
  • 305 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.